This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nature Reviews Cardiology, Published online: 18 November 2024; doi:10.1038/s41569-024-01100-3 Cholesterol crystals (CCs) have a pathogenic role in various cardiovascular diseases, particularly atherosclerosis.
As we step into 2024, the field of cardiology continues to offer exciting opportunities for knowledge exchange and networking at in-person conferences. Here is a preview of the upcoming cardiology conferences planned for 2024. Fees: Visit the ESC ACVC 2024 website for registration options. Hashtag: #ACVC2024 2.
Nature Reviews Cardiology, Published online: 11 September 2024; doi:10.1038/s41569-024-01075-1 The immune response is not unlike a game of chess, with white and black pieces playing opposing roles and orchestrating an opening, a middle and an endgame of innate immunity, adaptive immunity and resolution, respectively.
BackgroundInflammation, as the basic pathogenic mechanism of atherosclerosis, promotes the development of atherosclerosis (AS) and atherosclerotic cardiovascular disease (ASCVD). Two reviewers independently screened articles and extracted data.
Nature Reviews Cardiology, Published online: 20 September 2024; doi:10.1038/s41569-024-01072-4 In this Review, the authors describe the bidirectional crosstalk between lysosome biology and immune cell function and polarization, focusing on immunometabolic reprogramming in the context of atherosclerosis and highlighting knowledge gaps and potential (..)
Nature Reviews Cardiology, Published online: 10 April 2024; doi:10.1038/s41569-024-01016-y In this Review, Kemper and colleagues discuss the canonical and non-canonical roles of the complement system in the pathogenesis of atherosclerosis and discuss potential new therapeutic strategies targeting the complement system for the prevention and treatment (..)
HEART UK held its 37 th Annual Medical and Scientific Conference between 10 th –12 th July. This year, the cholesterol charity took on an international theme, looking at the global cardiovascular disease (CVD) prevention picture.
mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting. “We
Nature Reviews Cardiology, Published online: 25 April 2024; doi:10.1038/s41569-024-01023-z In this Review, the authors discuss the receptors, ligands and interactors that regulate immune cell recruitment in atherosclerosis, describe mechanisms that promote the resolution of inflammation in atherosclerotic lesions, and highlight potential strategies (..)
Nature Reviews Cardiology, Published online: 18 October 2024; doi:10.1038/s41569-024-01095-x Consumption of a high-fat diet leads to the progressive growth of atherosclerotic lesions. The mechanisms for accelerated atherosclerosis include reprogramming of macrophages and neutrophils.
Sara Diaz Savaria, MD, discusses a study from ESC Congress 2024 examining the utility of cancer history in women as a predictor of subclinical atherosclerosis.
The 2025 AHA Statistical Update is the product of a full years worth of effort in 2024 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members.
Introduction The British Cardiovascular Society (BCS)/British Heart Foundation (BHF)/British Atherosclerosis Society (BAS)/British Society for Cardiovascular Research (BSCR) Young Investigator Award (YIA) was established in 2001. This year, five finalists were selected from 49 applicants.
Nature Reviews Cardiology, Published online: 12 March 2024; doi:10.1038/s41569-024-01007-z Shoaran and Maffia recount how our understanding of the role of inflammation in atherosclerosis has evolved and highlight the study by Göran Hansson and colleagues that provided the first hint of the involvement of the adaptive immune response in atherosclerosis. (..)
Nature Reviews Cardiology, Published online: 12 January 2024; doi:10.1038/s41569-023-00984-x In this Review, Fredman and Serhan discuss the role of specialized pro-resolving mediators, a superfamily of endogenous signalling lipids that mediate resolution of inflammation processes in atherosclerosis, and appraise the therapeutic potential of specialized (..)
The 2024 AHA Statistical Update is the product of a full year’s worth of effort in 2023 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members.
Important Deadlines: 09 Jan 2025: Abstracts submission 21 Jan 2025: Clinical cases submission 28 Feb 2025: Congress Grants Deadline 14 Mar 2025: Late-Breaking Science submission 17 Mar 2024: Early registration savings Fees: Visit ESC Heart Failure 2025 website for registration options.
Designed to give healthcare professionals an understanding of lipid metabolism and its role in atherosclerosis. Module first published 9 July 2015 Module first revised 17 March 2021 Second revision June 2024
milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024. JACC Cardiovasc Imaging.
Circulation, Volume 150, Issue Suppl_1 , Page A4132968-A4132968, November 12, 2024. CCR5, a chemokine receptor, has been associated with both immunosuppressive and inflammatory phenotypes, however, the possible role of CCR5 pertaining to MDSCs in the development of atherosclerosis has not been elucidated yet. 3ng/day for 15 days).M-MDSCs
Circulation, Volume 150, Issue Suppl_1 , Page A4122717-A4122717, November 12, 2024. Recent studies implicate EndMT in atherosclerosis development. Diabetes is associated with both EndMT as well as accelerated atherosclerosis.
Circulation, Volume 150, Issue Suppl_1 , Page A4129709-A4129709, November 12, 2024. Background:The current unmet needs for aspirin usage in atherosclerosis lie in its short half-life and narrow indication for anti-platelet effects.
milla1cf Tue, 01/09/2024 - 11:32 January 9, 2024 — Cleerly , the company working to create a new standard of care for the diagnosis of heart disease, announced the launch of Cleerly ISCHEMIA , which recently received U.S. Food and Drug Administration (FDA) 510(k) medical device clearance.
Evidence has shown that carotid artery geometries are independently associated with ipsilateral MCA atherosclerosis. Conclusions:Both the lumen area and hemodynamics at the ipsilateral C1 were lower than those at the contralateral C1 in patients with unilateral MCA atherosclerosis. 21.35), p<0.001).Conclusions:Both
25, 2024 in the European Heart Journal Cardiovascular Imaging. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1. In Press European Heart Journal CV Imag 2024.This This study was sponsored by Cleerly, Inc. James Min, M.D. and James Earls, M.D.
Stroke, Volume 55, Issue Suppl_1 , Page AWP139-AWP139, February 1, 2024. We hypothesized that intracranial atherosclerosis, which is seen predominantly in older patients, affects vasospasm risk in aSAH. This may suggest intracranial atherosclerosis may affect TCD velocities without any clinical correlation.
milla1cf Tue, 01/23/2024 - 13:44 January 23, 2024 — HeartFlow, Inc. , a leader in non-invasive artificial intelligence (AI) precision coronary solutions, announced FFRCT was transitioned to a Category I Current Procedural Terminology (CPT) code beginning January 1, 2024.
milla1cf Tue, 03/26/2024 - 13:00 March 26, 2024 — Esperion announced the acceptance of three CLEAR ( C holesterol L owering via B e mpedoic acid, an A CL-Inhibiting R egimen ) Outcomes subgroup analyses as poster presentations at th e 2024 American College of Cardiology’s Annual Scientific Session ( ACC.24
Thus, angiography may be fairly accurate in determining lumen size, but it will not detect the “volume” of atherosclerosis present. If the adjacent segment has some mild luminal narrowing, the amount of arterial luminal narrowing compared with a totally normal artery will also be underestimated.
The 2024 report from the Lancet Standing Commission on Dementia Prevention, Intervention, and Care brings promising developments for healthcare professionals and public health advocates. The Takeaway The 2024 Lancet Commission report is a call to action for healthcare providers and public health advocates. Michos, MD ; Pamela B.
Stroke, Volume 55, Issue Suppl_1 , Page AWP116-AWP116, February 1, 2024. Both lumen stenosis and plaque components were correlated with multiple or recurrent infarcts in this population.
Getty Images milla1cf Mon, 06/10/2024 - 18:02 June 10, 2024 — New expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) reviews previously published qualitative and semi-quantitative measurements – including clinical guidelines like CAD-RADS 2.0
Stroke, Volume 55, Issue Suppl_1 , Page ATP300-ATP300, February 1, 2024. Background:Most ischemic strokes are caused by atherosclerosis. Apolipoprotein E (ApoE) regulates lipid metabolism, and its deficiency is associated with dyslipidemia and atherosclerosis. Poor dietary habits promote the onset of atherosclerosis.
ApoB Atherosclerosis, by definition, is caused by the retention of an ApoB lipid particle in the artery wall. This retained particle then sets off an inflammatory cascade, which ultimately results in the formation of atherosclerosis 1. Mechanism of atherosclerosis formation. 2024 Jan 14. Atherosclerosis.
Circulation, Volume 150, Issue Suppl_1 , Page A4144040-A4144040, November 12, 2024. Background:Coronary heart disease (CHD) remains the primary cause of mortality and morbidity in the USA. Although rodents are widely used to explore mechanisms, they have major biological differences with humans.
The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of the Division of Cardiology at UCLA, effective July 1, 2024. Hsue will come to UCLA from UC San Francisco (UCSF), where she leads a portfolio of clinical and translational studies on HIV-related cardiovascular disease and Long COVID.
Stroke, Volume 55, Issue Suppl_1 , Page ATP142-ATP142, February 1, 2024. Introduction:Perfusion imaging has been used to assess collateral status in patients with acute ischemic stroke secondary to anterior large-vessel occlusion.
tim.hodson Thu, 08/15/2024 - 10:32 Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for many Americans, according to a study led by UT Southwestern Medical Center researchers and published in JAMA Cardiology. Ann Marie Navar, M.D., Physicians following U.S.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content